At this time, no generic Tekturna (aliskiren) products are available in the United States. The first patent for the medication is set to expire in April 2015, which is the earliest predictable date a generic version could become available. If you search the Internet, you may find companies claiming to sell generic Tekturna. However, these drugs may be fake, substandard, and potentially dangerous.
Generic Tekturna: An OverviewTekturna® (aliskiren hemifumarate) is a prescription medication approved to treat high blood pressure (hypertension). It is classified as a renin inhibitor and is the first medication in this class.
Tekturna is made by Novartis Pharmaceuticals Corporation. It is currently under the protection of a patent that prevents any generic Tekturna from being manufactured in the United States. However, if you search the Internet for "generic Tekturna," you may find a number of companies claiming to sell it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Tekturna may be available from another country, but there is no way of knowing if you are getting genuine Tekturna. Therefore, you should not buy any generic versions until an approved version is available.